Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-043867
Filing Date
2024-04-12
Accepted
2024-04-12 08:02:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A mura-defa14a-2023_live.htm DEFA14A 25460
2 GRAPHIC img20420043_0.jpg GRAPHIC 2311486
3 GRAPHIC img20420043_1.jpg GRAPHIC 1783428
  Complete submission text file 0000950170-24-043867.txt   5666527
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Filer) CIK: 0001971543 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41837 | Film No.: 24840023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)